Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Better Therapeutics, Inc.
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
2
0
0
0
No Price
30.04.2026 20:00
Current Prices from Better Therapeutics, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
BTTX
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
NASDAQ
BTTX
USD
28.04.2026 19:50
0,0001 USD
-
Share Float & Liquidity
Free Float69,83 %
Shares Float38,07 M
Shares Outstanding54,52 M
Company Profile for Better Therapeutics, Inc. Share
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
